Document is current
Any future updates will be listed below
-
Authors
Beheshti, Mohsen https://orcid.org/0000-0003-3918-3812
Taimen, Pekka
Kemppainen, Jukka
Jambor, Ivan
Müller, Andre
Loidl, Wolfgang
Kähkönen, Esa
Käkelä, Meeri
Berndt, Mathias
Stephens, Andrew W.
Minn, Heikki
Langsteger, Werner
-
Funding
Funding for this research was provided by:
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 9 January 2022
Revised: 12 April 2022
Accepted: 12 June 2022
First Online: 21 July 2022
Declarations
:
: The scientific guarantor of this study is Mohsen Beheshti MD, FEBNM, FASNC, professor and head of the Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine & Endocrinology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria
: Andre Müller, Mathias Berndt, and Andrew W. Stephens are employees of Life Molecular Imaging GmbH (previous Piramal Imaging GmbH), Berlin, Germany. The other authors declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) this study.
: Institutional Review Board approval was obtained. The study has been also registered in the European Clinical Trial Register with the register number of EudraCT-Nr.: 2014-003027-21.
: • Prospective• Diagnostic or prognostic study• Multicenter study
